0001567619-20-021476.txt : 20201222 0001567619-20-021476.hdr.sgml : 20201222 20201222130957 ACCESSION NUMBER: 0001567619-20-021476 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201222 DATE AS OF CHANGE: 20201222 EFFECTIVENESS DATE: 20201222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Soley Therapeutics, Inc. CENTRAL INDEX KEY: 0001830785 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-384030 FILM NUMBER: 201407164 BUSINESS ADDRESS: STREET 1: 1 CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (415) 850-9841 MAIL ADDRESS: STREET 1: 1 CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0708 D LIVE 0001830785 Soley Therapeutics, Inc. 1 Corporate Drive South San Francisco CA CALIFORNIA 94080 (415) 850-9841 DELAWARE None None Corporation true Ken V. Alwyn 1 Corporate Drive South San Francisco CA CALIFORNIA 94080 Executive Officer Director Chief Financial Officer Kurosh Ameri 1 Corporate Drive South San Francisco CA CALIFORNIA 94080 Director Yerem Yeghiazarians 1 Corporate Drive South San Francisco CA CALIFORNIA 94080 Director Biotechnology Decline to Disclose 06b false 2020-10-15 false true false 0 20000000 20000000 0 false 32 0 0 0 false Soley Therapeutics, Inc. /s/ Ken V. Alwyn Ken V. Alwyn Chief Financial Officer 2020-12-18